Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
107 hedge funds and large institutions have $495M invested in Intersect ENT, Inc in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 12 closing their positions.
1% less funds holding
Funds holding: 108 → 107 (-1)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
19% less capital invested
Capital invested by funds: $611M → $495M (-$116M)
25% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 44
54% less call options, than puts
Call options by funds: $651K | Put options by funds: $1.42M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.5M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$13.2M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$12.6M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$3.26M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$2.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$11.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.4M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$7.08M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.27M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.73M |
XENT Hedge Fund Activity: Q2 2021 in Review
107 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2021, worth a combined $495M — down 19% from $611M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of XENT and 11 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 33 added.
The largest buyer was Fidelity Investments, adding an estimated $13.5M. The largest seller was Great Point Partners, cutting an estimated $11.8M.
- 107 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2021, down from 108 in Q1 2021.
- Funds reported $495M of Intersect ENT, Inc stock for Q2 2021, down 19% quarter-over-quarter.
- 11 funds opened new Intersect ENT, Inc positions in Q2 2021 and 12 closed out, a net change of -1 holder.
- The largest Intersect ENT, Inc buyer in Q2 2021 was Fidelity Investments, an estimated $13.5M added.
- The largest Intersect ENT, Inc seller in Q2 2021 was Great Point Partners, an estimated $11.8M sold.
Based on aggregated 13F filings for Q2 2021.